Advarra is a company within the Healthcare Technology and Services category. Advarra is a leading provider of clinical trial compliance solutions, offering ethical review services (IRB/IBC) and site-centric technology platforms. It serves as a connector between sponsors, CROs, and research sites to accelerate clinical research while maintaining safety and compliance.
Advarra was founded in 2017 and is headquartered in Columbia, MD.
Advarra is rated Leader on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Advarra is Moderate. Significant factual deltas detected. Inconsistent representation across models.
AI models classify Advarra as a Challenger. AI names competitors first.
Advarra appeared in 6 of 8 sampled buyer-intent queries (75%). Advarra dominates queries related to IRBs and CTMS, but has less visibility in broader 'Clinical AI' or 'Decentralized Trial' unbranded queries.
AI reliably identifies Advarra as a leader in clinical trial compliance and IRB services. However, it may struggle to accurately detail the current state of its software integrations following multiple acquisitions, often defaulting to its 2017 merger history. Key gap: AI often treats Advarra primarily as a service-based IRB/IBC firm, under-representing its massive pivot into a software-integrated 'Clinical Trial Ecosystem' provider.
Of 5 key facts verified about Advarra, 3 are well-documented (likely accurate across AI models), 2 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
The specifics of recent private equity ownership and the exact breadth of their software suite versus legacy services.
Buyers turn to Advarra for Manual Spreadsheet Tracking: Using Microsoft Excel or internal SharePoint sites to track clinical trial regulatory documents and site approvals manually., Third-party Compliance Consultants: Hiring third-party clinical research consultants or independent IRBs to manage the review process on a project-by-project basis., among 2 documented problem areas.
Buyers evaluating Advarra typically ask AI models about "Best CTMS for academic medical centers", "Independent Institutional Review Board services", "IBC review companies", and 3 similar queries.
Advarra's core products are Institutional Review Board (IRB) Services, Institutional Biosafety Committee (IBC) Services, OnCore CTMS, Longboat Platform, Consulting Services..
Advarra uses Enterprise/Custom.
Advarra serves Pharmaceutical Companies, CROs, Academic Medical Centers, Health Systems, Biotech..
Advarra The only major provider that integrates the world's most widely used site-side CTMS with top-tier ethical review services to bridge the gap between sites and sponsors.
Brand Authority Index (BAI) tier: Leader (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/advarra
Last analyzed: April 10, 2026
Founded: 2017 (Chesapeake/Schulman merger)
Headquarters: Columbia, Maryland, USA